ASX:MVF Monash IVF Group (MVF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Monash IVF Group Stock (ASX:MVF) 30 days 90 days 365 days Advanced Chart Get Monash IVF Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume9.00 million shsAverage VolumeN/AMarket CapitalizationA$455.87 millionP/E RatioN/ADividend Yield4.27%Price TargetN/AConsensus RatingN/A Company Overview Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia. Read More Receive MVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Monash IVF Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MVF Stock News HeadlinesDoes Macquarie rate Monash IVF shares a buy, hold, or sell post-results?August 26 at 7:23 AM | msn.comMonash IVF share price plunges 18% on lower FY26 profit guidance and no dividendAugust 23, 2025 | msn.comThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”August 29 at 2:00 AM | Weiss Ratings (Ad)Monash IVF Group Ltd Releases FY25 Results PresentationAugust 22, 2025 | msn.comFertility giant to keep review secret after two IVF bunglesAugust 20, 2025 | msn.comMonash IVF Group Completes Review of Clinic IncidentsAugust 20, 2025 | msn.comMonash IVF’s shares have plunged 25pc. This fundie says buy it nowAugust 12, 2025 | afr.comThis Monash IVF Group Insider Increased Their Holding In The Last YearAugust 5, 2025 | finance.yahoo.comSee More Headlines MVF Stock Analysis - Frequently Asked Questions How were Monash IVF Group's earnings last quarter? Monash IVF Group Limited (ASX:MVF) released its quarterly earnings results on Monday, August, 27th. The company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.10 by $0.01. Monash IVF Group had a negative net margin of 2.56% and a negative trailing twelve-month return on equity of 2.52%. What other stocks do shareholders of Monash IVF Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Monash IVF Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Surgery Partners (SGRY), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX). Company Calendar Last Earnings8/27/2018Today8/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryFinancial Services Current SymbolASX:MVF CIKN/A Webwww.monashivfgroup.com.au Phone+61-3-94208235FaxN/AEmployees997Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth8.25Net Income-A$6.53 million Net Margins-2.56% Pretax MarginN/A Return on Equity-2.52% Return on Assets-0.62% Debt Debt-to-Equity Ratio55.96 Current Ratio0.47 Quick Ratio0.43 Sales & Book Value Annual SalesA$255.22 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow27.14 Book ValueA$0.64 per share Price / BookN/AMiscellaneous Outstanding Shares389,640,000Free FloatN/AMarket CapA$455.87 million OptionableNot Optionable Beta1.40 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (ASX:MVF) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monash IVF Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Monash IVF Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access